5 Innovations in Doxorubicin Delivery Systems Advancing Cancer Care in 2026
Redefining How Doxorubicin Reaches Tumors Doxorubicin, a cornerstone anthracycline chemotherapy agent, has been pivotal in treating cancers like leukemia, lymphoma, and solid tumors for decades. Yet, its efficacy is often hindered by challenges such as cardiotoxicity, uneven tumor distribution, and reliance on intravenous (IV) administration. By 2026, advancements in delivery systems are...
ไลค์
รัก
3
1 ความคิดเห็น 0 แชร์ 299 ยอดวิว 0 รีวิว